Bedrijfsoverzicht
Yatsen Holding Limited, operating under the ticker YSG, is primarily engaged in the development and commercialization of beauty products within the People's Republic of China. The company structures its operations through three distinct segments, specifically focusing on Color Cosmetics Brands, Skincare Brands, and other categories, which collectively position it within the broader Consumer Defensive sector and the Household & Personal Products industry. This industry classification implies a business model that typically exhibits defensive characteristics against economic downturns, as consumer demand for personal care items often remains resilient. In terms of scale, the company holds a market capitalization of $298.93M and reports a trailing twelve-month revenue of $4.30B, while the employee count is currently listed as N/A. The substantial disparity between the market cap of $298.93M and the annual revenue of $4.30B suggests that the market is pricing in significant future risks or a lack of current profitability, rather than valuing the entity based on its current top-line generation capabilities.
Financiële gezondheid
The company reported a revenue of $4.30B for the trailing twelve months, yet this top-line performance is contrasted by a net income of $-80,868,000 and an EBITDA of $-35,169,000. The significant gap between the $4.30B revenue and the negative net income of $-80,868,000 reveals a cost structure where operating expenses, including the cost of goods sold and administrative costs, far exceed the gross profits generated from sales. While the company holds a cash position of $1.01B, the free cash flow is listed as N/A, indicating that the conversion of earnings into actual cash flow is either not materialized or not disclosed, which limits the assessment of immediate financial flexibility for capital expenditures or debt repayment. The gross margin stands at an impressive 78.2%, indicating strong pricing power or high-margin supply chains in its beauty product lines, but this is offset by an operating margin of -0.9% and a profit margin of -1.9%, which signal that overhead costs are eroding the bottom line. On the liability side, the company holds $176.59M in debt against $1.01B in cash, resulting in a debt-to-equity ratio of 5.88, which suggests a leveraged balance sheet where equity is relatively small compared to the total debt load. Despite the leverage, the current ratio of 3.63 indicates a robust short-term liquidity position, as the company holds significantly more current assets than current liabilities. Furthermore, the return on equity is -3.0% and the return on assets is -3.0%, metrics that collectively reveal that management effectiveness has been negative in terms of generating returns on the capital invested by shareholders and deployed in assets.
Waarderingsbeoordeling
The valuation metrics present a complex picture, with a trailing P/E ratio listed as N/A due to the negative earnings, while the forward P/E is 5.82. The stark difference between a non-existent trailing P/E and a forward P/E of 5.82 implies that the market is pricing in a complete turnaround in earnings trajectory, expecting the company to move from negative earnings to profitability in the near future. The price-to-book ratio is 0.68, which indicates that the stock is trading at a discount relative to its book value, suggesting the market does not currently assign a premium to the company's assets. Alternative valuation metrics further highlight the disconnect between current prices and fundamentals, as the price-to-sales ratio is 0.07 and the EV/EBITDA is -145.72. The 52-week high is recorded at $11.57 and the low at $2.87, meaning the current price sits significantly below the 52-week high, reflecting a period of depressed valuation relative to its recent trading range. The beta value of -1.77 is highly unusual and indicates that the stock's price volatility moves inversely to the broader market with extreme intensity, making its risk profile distinct from standard equities.
Growth & Income
The revenue growth year-over-year is 20.1%, demonstrating a robust expansion in the top line, whereas the earnings growth year-over-year is N/A due to the negative net income position. The fact that revenue is growing at 20.1% while earnings remain negative implies that the company is investing heavily in growth initiatives that are currently depressing profitability rather than generating immediate returns. As a non-dividend payer, the company does not distribute dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means all available earnings or retained cash are theoretically reinvested into the business operations or used to service debt rather than being distributed to shareholders. The overall growth and income profile is characterized by strong revenue expansion coupled with a lack of current profitability and dividend distribution, positioning the stock as a high-risk, high-growth candidate that relies on future operational improvements to convert sales growth into net income.